Skip to content
Screener

Insulet PODD Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
893.7M-0.7%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
69M+2.9%
Medtronic logo
MedtronicMDT
1.3B-0.1%
Beta Bionics logo
Beta BionicsBBNX
44.5M+2.7%
Opko Health logo
Opko HealthOPK
755.3M-4.2%
VAN
Vivani MedicalVANI
81.3M+37.2%

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.23B-52.7%
Enterprise value$9.67B-52.3%
P/E24.6×-58.1×
P/S-5.2×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions, except share and per share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Income tax expense(23.7)(5.9)(45.6)(18.6)
Net income$95.0$22.5$186.1$57.9
Earnings per share:
Basic$1.37$0.32$2.67$0.82
Diluted$1.37$0.32$2.67$0.82
Weighted-average number of common shares outstanding (in thousands):
Basic69,29870,38969,64270,330
Diluted69,40370,65269,80370,641

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's shares (diluted)?
Insulet (PODD) reported shares (diluted) of 69.4M in Q2 2026.
How has Insulet's shares (diluted) changed year-over-year?
Insulet's shares (diluted) decreased by 1.8% year-over-year, from 70.7M to 69.4M.
What is the long-term trend for Insulet's shares (diluted)?
Over 4 years (2021 to 2025), Insulet's shares (diluted) has grown at a 1.5% compound annual growth rate (CAGR), from 271M to 287.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Insulet's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude